EXFORGE HCT 10 mg/160 mg/
As listed in the register: EXFORGE HCT 10 mg/160 mg/25 mg, comprimé pelliculé
25 mg + 160 mg + 13,87 mg · comprimé pelliculé
- Prescription only
- Active substance
- Hydrochlorothiazide + Valsartan + Bésilate D'amlodipine
- Made by
- NOVARTIS EUROPHARM (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | NOVARTIS EUROPHARM (IRLANDE) |
|---|---|
| Active substance | Hydrochlorothiazide + Valsartan + Bésilate D'amlodipine |
| Strength | 25 mg + 160 mg + 13,87 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/09/569 |
| Name in the register | EXFORGE HCT 10 mg/160 mg/25 mg, comprimé pelliculé |
| Packs | plaquette(s) PVC PVDC de 30 comprimé(s) |
| CIS | 61045063 |
| CIP13 | 3400939733647 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Hydrochlorothiazide + Valsartan + Bésilate D'amlodipine